CN¥34.88
2.52%
Shanghai, Sep 24, 03:00 pm CST.
ISIN
CNE100003FF7
Symbol
688180

Shanghai Junshi Bioscience-h Target price 2026 - Analyst rating & recommendation

Shanghai Junshi Bioscience-h Classifications & Recommendation

Buy
71%
Hold
14%
Sell
14%

Shanghai Junshi Bioscience-h Price Target

Target Price CN¥54.06
Price CN¥34.88
Potential
Number of Estimates 3
3 Analysts have issued a price target Shanghai Junshi Bioscience-h 2027 . The average Shanghai Junshi Bioscience-h target price is CN¥54.06. This is higher than the current stock price. The highest price target is
CN¥55.65 59.55%
register free of charge
, the lowest is
CN¥53.53 53.47%
register free of charge
.
A rating was issued by 7 analysts: 5 Analysts recommend Shanghai Junshi Bioscience-h to buy, 1 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Shanghai Junshi Bioscience-h stock has an average upside potential 2027 of . Most analysts recommend the Shanghai Junshi Bioscience-h stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion CN¥ 2.50 3.38
28.23% 35.17%
EBITDA Margin -26.55% -4.44%
51.06% 83.28%
Net Margin -35.03% -9.66%
46.72% 72.42%

6 Analysts have issued a sales forecast Shanghai Junshi Bioscience-h 2026 . The average Shanghai Junshi Bioscience-h sales estimate is

CN¥3.4b
unlock
. This is
11.59% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CN¥3.6b 18.86%
unlock
, the lowest is
CN¥3.2b 6.44%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CN¥2.5b 28.23%
2026
CN¥3.4b 35.17%
unlock
2027
CN¥4.3b 26.00%
unlock
2028
CN¥5.0b 17.04%
unlock
2029
CN¥6.6b 33.01%
unlock
2030
CN¥8.1b 22.24%
unlock
2031
CN¥9.5b 17.24%
unlock
2032
CN¥11.1b 17.31%
unlock
2033
CN¥13.7b 23.16%
unlock

4 Shanghai Junshi Bioscience-h Analysts have issued a net profit forecast 2026. The average Shanghai Junshi Bioscience-h net profit estimate is

CN¥-326m
unlock
. This is
25.98% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CN¥-64.7m 85.33%
unlock
, the lowest is
CN¥-487m 10.47%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CN¥-875m 31.68%
2026
CN¥-326m 62.72%
unlock
2027
CN¥12.1m 103.71%
unlock
2028
CN¥342m 2,725.21%
unlock

Net Margin

2025 -35.03% 46.72%
2026
-9.66% 72.42%
unlock
2027
0.28% 102.90%
unlock
2028
6.86% 2,350.00%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CN¥ -0.87 -0.32
33.08% 63.22%
P/E negative
EV/Sales 9.76

4 Analysts have issued a Shanghai Junshi Bioscience-h forecast for earnings per share. The average Shanghai Junshi Bioscience-h EPS is

CN¥-0.32
unlock
. This is
15.79% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CN¥-0.06 84.21%
unlock
, the lowest is
CN¥-0.47 23.68%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CN¥-0.87 33.08%
2026
CN¥-0.32 63.22%
unlock
2027
CN¥0.01 103.13%
unlock
2028
CN¥0.33 3,200.00%
unlock

P/E ratio

Current -91.79 123.22%
2026
-109.75 19.57%
unlock
2027
2,959.27 2,796.37%
unlock
2028
104.76 96.46%
unlock

Based on analysts' sales estimates for 2026, the Shanghai Junshi Bioscience-h stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.89
2026
9.76 10.35%
unlock
2027
7.75 20.64%
unlock
2028
6.62 14.56%
unlock
2029
4.98 24.82%
unlock
2030
4.07 18.19%
unlock
2031
3.47 14.71%
unlock
2032
2.96 14.75%
unlock
2033
2.40 18.80%
unlock

P/S ratio

Current
2026
9.10 10.39%
unlock
2027
7.22 20.64%
unlock
2028
6.17 14.56%
unlock
2029
4.64 24.82%
unlock
2030
3.79 18.19%
unlock
2031
3.24 14.70%
unlock
2032
2.76 14.76%
unlock
2033
2.24 18.80%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today